Projects funded by the NCN

Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a...

Call: PRELUDIUM 24 , Panel: NZ4

Principal investigator: Natalia Anna Lehman

Uniwersytet Medyczny w Lublinie

Actin cytoskeleton disorders as a pro-survival signaling activator and a therapeutic biomarker in Diffuse Large B-cell L...

Call: SONATA BIS 13 , Panel: NZ5

Principal investigator: dr Patryk Górniak

Instytut Hematologii i Transfuzjologii

Exploring kinase hyperactivation as an innovative approach for chemo-immunotherapy for B cell acute lymphoblastic leukem...

Call: PRELUDIUM BIS 5 , Panel: NZ7

Principal investigator: dr hab. Małgorzata Firczuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

Instytut Farmakologii PAN

The role of microbiota-triggered antigen stimulation in development and progression of chronic lymphocytic leukemia

Call: OPUS 15 , Panel: NZ5

Principal investigator: prof. Krzysztof Giannopoulos

Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

B cell TLR9 receptor in regulation of immune tolerance in pregnancy

Call: PRELUDIUM 14 , Panel: NZ5

Principal investigator: Daria Magdalena Lorek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Influence of the B cell receptor (BCR) signaling pathways on CD20 levels in tumor cells and antitumor activity of anti-C...

Call: OPUS 4 , Panel: NZ6

Principal investigator: dr Magdalena Winiarska

Warszawski Uniwersytet Medyczny, I Wydział Lekarski